SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending due to heightened volatility and intense community debate as investors brace for the upcoming earnings report. While some discuss the stock's potential for a short squeeze and long-term growth, many are concerned about recent margin pressure and mixed brand performance.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing a significant surge following an earnings report that exceeded revenue expectations and featured raised full-year guidance. The community is actively discussing the potential for a massive short squeeze, driven by a high short interest and institutional confidence, as traders look for the stock to sustain its momentum and reclaim previous price levels.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing intense community discussion ahead of its upcoming earnings call, with investors closely watching for updates on potential Matrix-M licensing deals and the progress of its COVID-Influenza combination (CIC) vaccine program. While the stock has faced downward pressure due to perceived management silence and short interest, bulls are focused on patent filings that suggest potential expansion of Matrix-M into oncology and mRNA partnerships as key catalysts for future value.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is facing significant volatility following mixed second-quarter results and guidance that missed consensus expectations, triggering an intense debate among investors over its valuation and growth momentum. While some in the community see the sharp sell-off as a temporary overreaction to a solid quarter, others remain skeptical about the sustainability of its premium valuation amidst competitive pressures in the ad-tech sector.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is currently trending as investors monitor technical breakout levels and sector rotation toward managed care. The community is actively discussing the company's membership growth, improved medical loss ratios, and ongoing speculation regarding potential consolidation within the healthcare insurance space.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital shares are trending following a sharp sell-off as investors re-evaluate memory and storage valuations amid broader semiconductor sector volatility and concerns regarding increased supply competition. The community is actively debating whether this decline represents a buying opportunity in a long-term AI-driven supercycle or the inevitable bursting of a cyclical bubble.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is trending as investors react to a strong quarterly revenue beat and a record contracted backlog, sparking active debates over the company's ability to translate this operational growth into durable profitability. Community discussion is heavily focused on the stock's high short interest, the potential for a short squeeze, and the broader rotation of capital into defense and space-related sectors.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management systems, as well as other tools, integrations, and native payment solutions. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is trending after a post-earnings selloff, driven by investor concerns over slowing revenue growth guidance and the challenges of integrating AI-driven, outcome-based pricing. While the community is actively debating whether the dip represents a buying opportunity for a resilient software leader or a sign of structural decline, sentiment remains split between long-term investors tracking institutional buybacks and traders focused on near-term execution risks.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is experiencing significant upward momentum as investors cheer its pivot toward high-growth AI and automotive applications, specifically its role in the TSMC Co-Packaged Optics supply chain. The community is heavily focused on the company's long-term potential in edge AI and smart glasses, with many discussing the stock's transition from a cyclical play to a key component of the broader AI hardware infrastructure.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is at the center of intense market debate as investors brace for the first major post-IPO lock-up expiration, which will release nearly 1 billion shares for potential sale and significantly expand the public float. While the community is deeply divided between bears pointing to heavy dilution and high cash burn, and bulls expecting a short squeeze or long-term growth, many are actively monitoring the stock for a potential move toward $100.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Benitec Biopharma (BNTC) Expected to Announce Earnings on Wednesday

Benitec Biopharma (NASDAQ:BNTC) will be releasing its Q3 2026 earnings before the market opens on Wednesday, May 13. (View Earnings Report at...

PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes...

Benitec Biopharma Limited (NASDAQ:BNTC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven analysts that are presently covering the firm...

Benitec Biopharma Limited (NASDAQ:BNTC) Receives Average Recommendation of "Moderate Buy" from Brokerages

Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seven ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold rec...

Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above 50 Day Moving Average - What's Next?

Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Above Fifty Day Moving Average - Time to Sell...

Benitec Biopharma Reports Promising Interim Results For BB-301 Gene Therapy In OPMD Trial

(RTTNews) - Benitec Biopharma Inc. (BNTC) on Monday, announced encouraging interim results from its Phase 1b/2a clinical study evaluating BB-301, a gene therapy for Oculopharyngeal Muscular Dystrophy...

Benitec Biopharma's (BNTC) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $32.00 price target on shares of Benitec Biopharma in a research report on Monday...

HC Wainwright Issues Optimistic Forecast for BNTC Earnings

Benitec Biopharma Limited (NASDAQ:BNTC - Free Report) - Equities researchers at HC Wainwright boosted their Q3 2026 earnings per share estimates for Benitec Biopharma in a research report issued on...

Analysts Issue Forecasts for BNTC Q1 Earnings

Benitec Biopharma Limited (NASDAQ:BNTC - Free Report) - Investment analysts at HC Wainwright issued their Q1 2027 earnings per share estimates for shares of Benitec Biopharma in a research report...

Benitec Biopharma Limited (NASDAQ:BNTC) Receives Consensus Rating of "Moderate Buy" from Brokerages

Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven analysts that are covering the stock, MarketBeat.com reports. One...

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.

Benitec Biopharma Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info